3D Printing of Pharmaceuticals and
Drug Delivery Devices

3D Printing of Pharmaceuticals and
Drug Delivery Devices

3D Printing,
Pharmaceuticals,
Drug Delivery Devices

The process of 3D printing (3DP) was patented in 1986; however, the research in the field of 3DP did not become popular until the last decade. There has been an increasing research into the areas of 3DP for medical applications for fabricating prosthetics, bioprinting and pharmaceutics.
This novel method allows the manufacture of dosage forms on demand, with modifications in the geometry and size resulting in changes to the release and dosage behaviour of the product. 3DP will
allow wider adoption of personalised medicine due to the diversity and simplicity to change the design and dosage of the products, allowing the devices to be designed specific to the individual
with the ability to alternate the drugs added to the product. Personalisation also has the potential to decrease the common side effects associated with generic dosage forms. This Special Issue Editorial
outlines the current innovative research surrounding the topic of 3DP, focusing on bioprinting and various types of 3DP on applications for drug delivery as well advantages and future directions in this field of research.

Dimitrios A. Lamprou (Editor)

https://www.mdpi.com/journal/pharmaceutics/
special
issues/3D Printing Pharmaceutic

MDPI
St. Alban-Anlage 66
4052 Basel, Switzerland

2020

Dimitrios A. Lamprou
J®F

CC BY-NC-ND.

PDF

English

Textbooks

ISBN 978-3-03936-423-7 (Hbk)
ISBN 978-3-03936-424-4 (PDF)